High-level multiplex amplification

Inventors

Chen, Peilin

Assignees

Standard Biotools Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11117113-B2

Patent

Publication Date

2021-09-14

Expiration Date


Abstract

The present disclosure provides a “looping amplification” method to increase the specificity of nucleic acid amplification. This increased specificity facilitates multiplexing to a much higher degree than was previously possible.

Core Innovation

A method for amplifying one or more target nucleic acids uses a forward primer and a reverse primer for each target nucleic acid, where each primer comprises a target-specific portion, a common sequence 5′ of the target-specific portion, and a DNA sequencing primer binding site 5′ of the common sequence. The primers further include a first or second nucleotide tag 5′ of the DNA sequencing primer binding site, with different nucleotide tags in the forward and reverse primers, and the common sequence comprises a transposon end sequence.

The target nucleotide sequence is flanked by the common sequence on one end and its reverse complement on the other end so that a single strand of the target amplicon can form a stem loop structure. A first amplification is carried out in a microfluidic device comprising a plurality of reaction chambers using a third primer comprising a portion specific for the second nucleotide tag, a barcode nucleotide sequence 5′ of the tag-specific portion, and a first flow cell attachment site 5′ of the barcode nucleotide sequence.

The first amplification produces first target amplicons and the first target amplicons are recovered from the microfluidic device after the first amplification. A second amplification is then performed on the recovered first target amplicons using a fourth primer having a portion specific for the first nucleotide tag and a second flow cell attachment site 5′ of the first nucleotide tag-specific portion, together with a reverse primer specific for the second flow cell attachment site.

This second amplification produces second target amplicons with a structure that places the tags, primer binding sites, common sequence and its reverse complement, and barcode nucleotide sequence in a configuration that includes the flow cell attachment sites. The resulting format supports multiplexing through the plurality of microfluidic reaction chambers in a two-step amplification scheme.

Claims Coverage

The provided claim content describes one independent claim centered on a two-step microfluidic amplification workflow with tag- and flow-cell-specific primer sets and a stem-loop-forming amplicon structure using a transposon end common sequence. Dependent claims further refine multiplexing, throughput, an optional matrix-type microfluidic format, and optional amplification additives.

Stem-loop-forming common transposon-end amplicon

Target nucleic acids are amplified using forward and reverse primers whose common sequence comprises a transposon end sequence, generating target amplicons in which the target nucleotide sequence is flanked by the common sequence on one end and its reverse complement on the other end, whereby a single strand of the target amplicon can form a stem loop structure.

Two-step amplification with tag-, barcode-, and flow-cell attachment site priming

A first amplification produces first target amplicons using a third primer with a portion specific for the second nucleotide tag, a barcode nucleotide sequence 5′ of the tag-specific portion, and a first flow cell attachment site 5′ of the barcode nucleotide sequence, followed by recovering the first target amplicons and performing a second amplification using a fourth primer having a portion specific for the first nucleotide tag and a second flow cell attachment site 5′ of the first nucleotide tag-specific portion, together with a reverse primer specific for the second flow cell attachment site.

Microfluidic device with plurality of reaction chambers

The first amplification is carried out in a microfluidic device comprising a plurality of reaction chambers, and the method includes recovering the first target amplicons from the microfluidic device after the first amplification.

Multiplex amplification across reaction chambers

The amplification is performed in multiplex across the plurality of reaction chambers.

Throughput-scaled multiplex of many target nucleic acids

More than 100 target nucleic acids are amplified in each of the plurality of reaction chambers.

Matrix-type microfluidic device implementation

The microfluidic device is a matrix-type microfluidic device.

High target-and-sample multiplexing

Simultaneous amplification of at least 4800 target nucleic acids from at least 48 samples is performed using a microfluidic device.

Amplification in the presence of 2-pyrrolidinone

The amplification is performed in the presence of 2-pyrrolidinone, optionally with trehalose.

The claim coverage centers on a two-step microfluidic amplification method that uses primers with a transposon end common sequence to generate stem-loop-forming amplicons, differentiates forward and reverse primers by different nucleotide tags, adds barcode nucleotide sequences and flow cell attachment sites in the first amplification, recovers first amplicons, and then adds a second flow cell attachment site in a second amplification using a tag-specific fourth primer and a reverse primer specific for the second flow cell attachment site. Dependent refinements add multiplexing across multiple chambers, numeric throughput constraints, an optional matrix-type microfluidic format, and optional inclusion of 2-pyrrolidinone and trehalose.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Not explicitly described in patent.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.